Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Alfuzosin reduces short-term surgery need after catheter removal, but long-term benefits are unclear; combination therapy may help prevent urinary issues.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Combining cyclosporine A and ketoconazole can effectively treat anal furunculosis in dogs, with some experiencing recurrences and mild side effects.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

mTOR may link different pathways in hair follicle tumor formation.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Finasteride, often used for hair loss, can potentially cause cataracts.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Adding baricitinib will increase costs but offers more treatment options for alopecia areata.

Antioxidants can block the cancer-fighting effects of doxorubicin.

Pulsed electric field treatment may help the immune system fight liver tumors.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

Disodium folinate can safely and effectively replace calcium folinate in colorectal cancer treatment.

34% of patients on hepatitis C treatment had reversible skin issues.

Erlotinib can cause excessive eyelash growth.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Some blood pressure medications are linked to a higher risk of skin cancer.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.